Drugs in the Lab and Some Other Things

I listened to a great conversation this week with Russ Roberts and Adam Cifu, MD. They spoke about Cifu’s recent paper, The Case For Being a Medical Conservative which takes a good hard look at evidence-based medicine.

Cifu said two things that had clear parallels to investing:

1- “Should evidence come with an expiration date?”

2-“Once we take a drug which looks great in the lab and put it in a human being, boy it’s a different game.”

His second point is perfectly captured by this tweet from Corey Hoffstein.

**

Would you want to bowl competitively against this robot?

You don’t see the computers when you press buy and sell at TD Ameritrade, but they’re a part of the machine. In the words of Adrian Balboa, “You can’t win!”

**

I saw Spider-Man: Far From Home. If you liked the first one, well I guess the seventh reboot of the first one, then you’re going to love this. They picked up where The Avengers left off and didn’t disappoint.

I still haven’t started season 2 of Dark because I just haven’t gotten around to it. In the meantime, my wife started watching Dead to Me and I jumped in after a few episodes (easy to catch up). It’s pretty good. And each episode is around 25 minutes long which makes a decent show 40% better. I’d put this in that category.

**

Bill Gurley was on Patrick’s podcast this week and they were talking about how much money there is searching for great ideas. Gurley said something to the effect of how hard it is to come up with new and I couldn’t help but think of that when I saw this tweet today.

Hope everyone has a nice weekend. Thanks for reading.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

The Compound Media, Inc., an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here: https://www.ritholtzwealth.com/advertising-disclaimers

Please see disclosures here.